Generic placeholder image

Current Nutrition & Food Science

Editor-in-Chief

ISSN (Print): 1573-4013
ISSN (Online): 2212-3881

Review Article

The Effects of Different Kinds of Nutrition and Functional Foods on Multiple Sclerosis

Author(s): Masih Falahatian*

Volume 16, Issue 5, 2020

Page: [632 - 637] Pages: 6

DOI: 10.2174/1573401316666200129115858

Price: $65

Abstract

It is an assumption that different kinds of nutrition, diet, and functional foods might have different positive or negative effects on multiple sclerosis (MS), a neuroinflammatory disease of the central nervous system (CNS). This brief paper involved a study on various kinds of nutrition including salt, fat, dairy, fruit, and vegetables. At the end of this study, appropriate diets were evaluated for MS patients. Based on previous studies both on animal models and on MS patients, excessive dietary salt intake and animal fat had worsening effects on MS patients but fruit and vegetable intake helped the remission of MS and decreased the risk of developing it. There were, of course, conflicting results in different studies over the role of some nutrition in MS and future studies on larger numbers of cases were required to collect reliable results. As a result, at the end of this study and based on literature, it is suggested that a diet should be programmed by nutritionists containing fewer salt, fat, and dairy intake and more fruits and vegetables for MS patients in order to better management of the disease.

Keywords: Diet, foods, immune system, multiple sclerosis, nutrition, regime.

Graphical Abstract

[1]
Houtchens MK, Bove R. A case for gender-based approach to multiple sclerosis therapeutics. Front Neuroendocrinol 2018; 50: 123-34.
[http://dx.doi.org/10.1016/j.yfrne.2018.07.001] [PMID: 30040969]
[2]
Farrokhi M, Beni AA, Etemadifar M, et al. Effect of fingolimod on platelet count among multiple sclerosis patients. Int J Prev Med 2015; 6: 125.
[http://dx.doi.org/10.4103/2008-7802.172539] [PMID: 26900439]
[3]
Zadeh AR, Farrokhi M, Etemadifar M, Beni AA. Prevalence of benign tumors among patients with multiple sclerosis. Am J Exp Clin Res 2015; 2(4): 127-32.
[4]
Nakashima I, Fujihara K, Miyazawa I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006; 77(9): 1073-5.
[http://dx.doi.org/10.1136/jnnp.2005.080390] [PMID: 16505005]
[5]
Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006; 113(2): 324-32.
[http://dx.doi.org/10.1016/j.ophtha.2005.10.040] [PMID: 16406539]
[6]
Postigo-Alonso B, Galvao-Carmona A, Benítez I, et al. Cognitive-motor interference during gait in patients with Multiple Sclerosis: a mixed methods Systematic Review. Neurosci Biobehav Rev 2018; 94: 126-48.
[http://dx.doi.org/10.1016/j.neubiorev.2018.08.016] [PMID: 30189226]
[7]
Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17(2): 162-73.
[PMID: 29275977]
[8]
Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69(2): 292-302.
[http://dx.doi.org/10.1002/ana.22366] [PMID: 21387374]
[9]
Rafiee Zadeh A, Ghadimi K, Mohammadi B, Naghibi S, Danaeiniya A. Effects of estrogen and progesterone on differ-ent immune cells related to multiple sclerosis. Caspian J Neurol Sci 2018; 4(2): 39-46.
[10]
Aleksić S, Pantović M, Pantović V. Enviromental factors and multiple sclerosis. J Neuroimmunol 1995; 56: 26.
[http://dx.doi.org/10.1016/0165-5728(95)98930-A]
[11]
Martinelli V, Dalla Costa G, Moiola L, Rodegher M, Colombo B, Di Maggio G, Eds. Predicting early conversion to multiple sclerosis in patients with clinically isolated syndromes: the importance of an integrated modeling of risk factors. J Neurol 2014; 5, S134
[12]
Payghani C, Khani F, Zadeh AR, Reisi P, Alaei H, Rashidi B. the effect of levothyroxine on serum levels of interleukin 10 and interferon-gamma in rat model of multiple sclerosis. Adv Biomed Res 2017; 6: 118.
[http://dx.doi.org/10.4103/abr.abr_267_16] [PMID: 28989911]
[13]
Taylor BV. The major cause of multiple sclerosis is environmental: genetics has a minor role--yes. Mult Scler 2011; 17(10): 1171-3.
[http://dx.doi.org/10.1177/1352458511421105] [PMID: 21980150]
[14]
Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 2007; 61(6): 504-13.
[http://dx.doi.org/10.1002/ana.21141] [PMID: 17492755]
[15]
Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 2010; 9(5): A387-94.
[http://dx.doi.org/10.1016/j.autrev.2009.11.010] [PMID: 19932200]
[16]
Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 2004; 291(15): 1875-9.
[http://dx.doi.org/10.1001/jama.291.15.1875] [PMID: 15100207]
[17]
Islam T, Gauderman WJ, Cozen W, Mack TM. Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology 2007; 69(4): 381-8.
[http://dx.doi.org/10.1212/01.wnl.0000268266.50850.48] [PMID: 17646631]
[18]
Arruti M, Castillo-Triviño T, Egüés N, Olascoaga J. [Smoking and multiple sclerosis]. Rev Neurol 2015; 60(4): 169-78.
[PMID: 25670047]
[19]
Habek M, Hojsak I, Brinar VV. Nutrition in multiple sclerosis. Clin Neurol Neurosurg 2010; 112(7): 616-20.
[http://dx.doi.org/10.1016/j.clineuro.2010.03.029] [PMID: 20444538]
[20]
Payne A. Nutrition and diet in the clinical management of multiple sclerosis. J Hum Nutr Diet 2001; 14(5): 349-57.
[http://dx.doi.org/10.1046/j.1365-277X.2001.00308.x] [PMID: 11906575]
[21]
Tripathi MK, Giri SK. Probiotic functional foods: survival of probiotics during processing and storage. J Funct Foods 2014; 9: 225-41.
[http://dx.doi.org/10.1016/j.jff.2014.04.030]
[22]
Riccio P, Rossano R. Nutrition facts in multiple sclerosis. ASN Neuro 2015; 7(1) 1759091414568185
[http://dx.doi.org/10.1177/1759091414568185] [PMID: 25694551]
[23]
Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013; 496(7446): 518-22.
[http://dx.doi.org/10.1038/nature11868] [PMID: 23467095]
[24]
Wu C, Yosef N, Thalhamer T, Zhu C, Xiao S, Kishi Y, et al. Induction of pathogenic Th17 cells by inducible salt sensing kinase SGK1 2013; 1145.
[25]
Farez MF, Fiol MP, Gaitán MI, Quintana FJ, Correale J. Sodium intake is associated with increased disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 2014; 2014, 307928
[26]
Koch-Henriksen N, Lauer K. Dietary sodium intake: An etiologic dead end in multiple sclerosis. Neurology 2017; 89(13): 1314-5.
[27]
Cortese M, Yuan C, Chitnis T, Ascherio A, Munger KL. No association between dietary sodium intake and the risk of multiple sclerosis. Neurology 2017; 89(13): 1322-9.
[http://dx.doi.org/10.1212/WNL.0000000000004417] [PMID: 28842447]
[28]
McDonald J, Graves J, Waldman A, et al. A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. Mult Scler Relat Disord 2016; 6: 87-92.
[http://dx.doi.org/10.1016/j.msard.2016.02.011] [PMID: 27063630]
[29]
Nourbakhsh B, Graves J, Casper TC, et al. Dietary salt intake and time to relapse in paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry 2016; 87(12): 1350-3.
[PMID: 313410]
[30]
Kappos L, Polman C, Freedman M, Eds. Betaferon® in newly emerging multiple sclerosis for initial treatment (BENEFIT): clinical results Multiple Sclerosis. England: Edward Arnold 2005.
[31]
Katz Sand I. The role of diet in multiple sclerosis: mechanistic connections and current evidence. Curr Nutr Rep 2018; 7(3): 150-60.
[http://dx.doi.org/10.1007/s13668-018-0236-z] [PMID: 30117071]
[32]
Hwang D, Huang S, Rutkowsky JM, et al. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J Lipid Res 2012; 53(9): 2002-13.
[33]
Timmermans S, Bogie JF, Vanmierlo T, et al. High fat diet exacerbates neuroinflammation in an animal model of multiple sclerosis by activation of the Renin Angiotensin system. J Neuroimmune Pharmacol 2014; 9(2): 209-17.
[http://dx.doi.org/10.1007/s11481-013-9502-4] [PMID: 24068577]
[34]
Riccio P, Rossano R. Diet, gut microbiota, and vitamins D+A in multiple sclerosis. Neurotherapeutics 2017; 15(1): 75-91.
[PMID: 29067566]
[35]
Azary S, Schreiner T, Graves J, et al. Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry 2018; 89(1): 28-33.
[PMID: 315936]
[36]
Zhang SM, Willett WC, Hernán MA, Olek MJ, Ascherio A. Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am J Epidemiol 2000; 152(11): 1056-64.
[http://dx.doi.org/10.1093/aje/152.11.1056] [PMID: 11117615]
[37]
Yadav V, Marracci G, Kim E, et al. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial. Mult Scler Relat Disord 2016; 9: 80-90.
[http://dx.doi.org/10.1016/j.msard.2016.07.001] [PMID: 27645350]
[38]
Weinstock-Guttman B, Baier M, Park Y, et al. Low fat dietary intervention with ω-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids 2005; 73(5): 397-404.
[http://dx.doi.org/10.1016/j.plefa.2005.05.024] [PMID: 16099630]
[39]
Bäärnhielm M, Olsson T, Alfredsson L. Fatty fish intake is associated with decreased occurrence of multiple sclerosis. Mult Scler 2014; 20(6): 726-32.
[http://dx.doi.org/10.1177/1352458513509508] [PMID: 24158977]
[40]
Hoare S, Lithander F, van der Mei I, Ponsonby A-L, Lucas R, Group AI. Ausimmune Investigator Group. Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: Results from the Ausimmune Study. Mult Scler 2016; 22(7): 884-92.
[http://dx.doi.org/10.1177/1352458515604380] [PMID: 26362904]
[41]
Ascherio A, Munger KL, White R, et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol 2014; 71(3): 306-14.
[http://dx.doi.org/10.1001/jamaneurol.2013.5993] [PMID: 24445558]
[42]
LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA 1999; 281(16): 1505-11.
[http://dx.doi.org/10.1001/jama.281.16.1505] [PMID: 10227320]
[43]
Solomon AJ. Patient page. Multiple sclerosis and vitamin D. Neurology 2011; 77(17): e99-e100.
[http://dx.doi.org/10.1212/WNL.0b013e318237c282] [PMID: 22025466]
[44]
Munger KL, Zhang SM, O’Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 62(1): 60-5.
[http://dx.doi.org/10.1212/01.WNL.0000101723.79681.38] [PMID: 14718698]
[45]
VanAmerongen BM, Dijkstra CD, Lips P, Polman CH. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr 2004; 58(8): 1095-109.
[http://dx.doi.org/10.1038/sj.ejcn.1601952] [PMID: 15054436]
[46]
Malosse D, Perron H, Sasco A, Seigneurin JM. Correlation between milk and dairy product consumption and multiple sclerosis prevalence: a worldwide study. Neuroepidemiology 1992; 11(4-6): 304-12.
[http://dx.doi.org/10.1159/000110946] [PMID: 1291895]
[47]
Guggenmos J, Schubart AS, Ogg S, et al. Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis. J Immunol 2004; 172(1): 661-8.
[http://dx.doi.org/10.4049/jimmunol.172.1.661] [PMID: 14688379]
[48]
Mische LJ, Mowry EM. The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a Review. Curr Treat Options Neurol 2018; 20(4): 8.
[http://dx.doi.org/10.1007/s11940-018-0494-5] [PMID: 29549521]
[49]
Munger KL, Chitnis T, Frazier AL, Giovannucci E, Spiegelman D, Ascherio A. Dietary intake of vitamin D during adolescence and risk of multiple sclerosis. J Neurol 2011; 258(3): 479-85.
[http://dx.doi.org/10.1007/s00415-010-5783-1] [PMID: 20945071]
[50]
Schwarz S, Leweling H. Multiple sclerosis and nutrition. Mult Scler 2005; 11(1): 24-32.
[http://dx.doi.org/10.1191/1352458505ms1119oa] [PMID: 15732263]
[51]
Hadgkiss EJ, Jelinek GA, Weiland TJ, Pereira NG, Marck CH, van der Meer DM. The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis. Nutr Neurosci 2015; 18(3): 125-36.
[http://dx.doi.org/10.1179/1476830514Y.0000000117] [PMID: 24628020]
[52]
Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun 2014; 38: 1-12.
[http://dx.doi.org/10.1016/j.bbi.2013.12.015] [PMID: 24370461]
[53]
Amara F, Berbenni M, Fragni M, et al. Neuroprotection by cocktails of dietary antioxidants under conditions of nerve growth factor deprivation. Oxidative medicine and cellular longevity 2015.
[http://dx.doi.org/10.1155/2015/217258]
[54]
Bagheri M, Maghsoudi Z, Fayazi S, Elahi N, Tabesh H, Majdinasab N. Several food items and multiple sclerosis: A case-control study in Ahvaz (Iran). Iran J Nurs Midwifery Res 2014; 19(6): 659-65.
[PMID: 25558266]
[55]
Ghadirian P, Jain M, Ducic S, Shatenstein B, Morisset R. Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol 1998; 27(5): 845-52.
[http://dx.doi.org/10.1093/ije/27.5.845] [PMID: 9839742]
[56]
Sedaghat F, Jessri M, Behrooz M, Mirghotbi M, Rashidkhani B. Mediterranean diet adherence and risk of multiple sclerosis: a case-control study. Asia Pac J Clin Nutr 2016; 25(2): 377-84.
[PMID: 27222422]
[57]
Rasmussen NF, Rubin KH, Stougaard M, et al. Impact of red meat, processed meat and fibre intake on risk of late-onset chronic inflammatory diseases: prospective cohort study on lifestyle factors using the Danish ‘Diet, Cancer and Health’ cohort (PROCID-DCH): protocol. BMJ Open 2019; 9(3) e024555
[http://dx.doi.org/10.1136/bmjopen-2018-024555] [PMID: 30928934]
[58]
Black LJ, Baker K, Ponsonby A-L, van der Mei I, Lucas RM, Pereira G. Ausimmune Investigator Group. A Higher Mediterranean Diet Score, Including Unprocessed Red Meat, Is Associated with Reduced Risk of Central Nervous System Demyelination in a Case-Control Study of Australian Adults. J Nutr 2019; 149(8): 1385-92.
[http://dx.doi.org/10.1093/jn/nxz089] [PMID: 31131415]
[59]
Altowaijri G, Fryman A, Yadav V. Dietary interventions and multiple sclerosis. Curr Neurol Neurosci Rep 2017; 17(3): 28.
[http://dx.doi.org/10.1007/s11910-017-0732-3] [PMID: 28317084]
[60]
Sattarnezhad N, Caron K, Chua A, et al. Effects of Red Meat Diet Restriction on Multiple Sclerosis Severity (P1. 404). Neurology Apr 2016; 86(16 Suppl.) P1.404
[61]
Nortvedt MW, Riise T, Maeland JG. Multiple sclerosis and lifestyle factors: the Hordaland Health Study. Neurol Sci 2005; 26(5): 334-9.
[http://dx.doi.org/10.1007/s10072-005-0498-2] [PMID: 16388368]
[62]
Bagur MJ, Murcia MA, Jiménez-Monreal AM, et al. Influence of diet in multiple sclerosis: a systematic review. Adv Nutr 2017; 8(3): 463-72.
[http://dx.doi.org/10.3945/an.116.014191] [PMID: 28507011]
[63]
Piccio L, Stark JL, Cross AH. Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. J Leukoc Biol 2008; 84(4): 940-8.
[http://dx.doi.org/10.1189/jlb.0208133] [PMID: 18678605]
[64]
Matveeva O, Bogie JFJ, Hendriks JJA, Linker RA, Haghikia A, Kleinewietfeld M. Western lifestyle and immunopathology of multiple sclerosis. Ann N Y Acad Sci 2018; 1417(1): 71-86.
[http://dx.doi.org/10.1111/nyas.13583] [PMID: 29377214]
[65]
Widmer RJ, Flammer AJ, Lerman LO, Lerman A. The Mediterranean diet, its components, and cardiovascular disease. Am J Med 2015; 128(3): 229-38.
[http://dx.doi.org/10.1016/j.amjmed.2014.10.014] [PMID: 25447615]
[66]
Riccio P, Rossano R, Larocca M, et al. Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study. Exp Biol Med (Maywood) 2016; 241(6): 620-35.
[http://dx.doi.org/10.1177/1535370215618462] [PMID: 26785711]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy